A randomised controlled single-blind multi-centre study to investigate the induction of ALUminium contact allergy in children/adults receiving hyposensitisation therapy due to allergic disease

ISRCTN ISRCTN57796160
DOI https://doi.org/10.1186/ISRCTN57796160
Secondary identifying numbers N/A
Submission date
25/09/2007
Registration date
08/02/2008
Last edited
20/10/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Magnus Bruze
Scientific

Department of Occupational and Environmental Dermatology
Malmö University Hospital
Malmö
205 02
Sweden

Phone +46 40 336516
Email magnus.bruze@med.lu.se

Study information

Study designRandomised, controlled, single-blind, multi-centre study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymALU study
Study objectivesThe development of persisting itching nodules at the injection site after desensitisation therapy with aluminium precipitated antigen extract has been described in several reports, and also after vaccination with aluminium adsorbed vaccines.

The overriding aim of the planned study is to investigate the proportion of children and adults who develop contact allergy to aluminium during hyposensitisation therapy and if development of allergy to aluminium is linked to a persistent itching subcutaneous nodule.
Ethics approval(s)Approval received from the local ethics committee (Regionala Etikprövningsnämnden i Lund, Avd 2) (ref: Dnr 277/2007)
Health condition(s) or problem(s) studiedAllergy
InterventionIntervention arm: Hyposensitisation therapy with aluminium precipitated antigen extract, used subcutaneously. The duration of hyposensitisation therapy varies between patients, as each patient receives a different course of treatment, depending on his/her condition.
Control arm: No treatment
Intervention typeOther
Primary outcome measure1. To estimate the proportion of children and adults who develop contact allergy to aluminium during the hyposensitisation therapy measured by patch testing
2. To compare the proportion of children and adults with positive patch test reactions to aluminum between groups, those with persistent nodules with or without itching and those without manifestations/symptoms

All patch testing will be performed in close connection with the injections, which means on the same day or the following days. The patch test reader will be blinded - he/she will not know which patient has already received the hyposensitisation therapy and which has not (and will be receiving).
Secondary outcome measures1. To investigate the frequency of contact allergy in atopic children (contact allergy to aluminium and other sensitizers present in the European Patch Test Series)
2. To compare the contact allergy rated between atopic children and adults with and without atopic dermatitis (contact allergy to aluminium and other sensitisers present in the European Patch Test Series)
3. To make comparison between groups considering the following possible risk factors for developing persisting itching nodules with contact allergy to aluminium:
3.1. Doses
3.2. Sex
3.3. Age
3.4. Other medication/exposure
Overall study start date27/08/2007
Completion date01/03/2009

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants500
Key inclusion criteria1. Children and adults who will start their hyposensitisation therapy during 2007 and 2008
2. Written informed consent
Key exclusion criteriaExperienced anaphylaxis during skin tests.
Date of first enrolment27/08/2007
Date of final enrolment01/03/2009

Locations

Countries of recruitment

  • Sweden

Study participating centre

Department of Occupational and Environmental Dermatology
Malmö
205 02
Sweden

Sponsor information

Malmö University Hospital (Sweden)
University/education

Department of Occupational and Environmental Dermatology
Malmö
205 02
Sweden

Website http://www.hand.mas.lu.se
ROR logo "ROR" https://ror.org/05wp7an13

Funders

Funder type

University/education

Department of Occupational and Environmental Dermatology, Malmö University Hospital, Malmö (Sweden)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan